Rasool AMA, Rashid AMS, Hassan EHA, Subhi A. REPURPOSING ORLISTAT AS A FATTY ACID SYNTHASE INHIBITOR IN BREAST CANCER: IN VITRO EFFICACY, MECHANISMS, AND SYNERGY WITH DOXORUBICIN. JMGCB [Internet]. 2025 Dec. 9 [cited 2026 Feb. 27];3(1):73-89. Available from: https://journal.antispublisher.id/index.php/JMGCB/article/view/1606